Stomach balloon study targets fatty liver and weight loss
NCT ID NCT07493967
First seen Mar 28, 2026 · Last updated Jun 13, 2026 · Updated 14 times
Summary
This study follows 200 people with nonalcoholic fatty liver disease (NAFLD) who get a temporary intragastric balloon to help with weight loss. Researchers will track changes in weight, liver enzymes, blood sugar, and liver stiffness for at least one year. The goal is to see if the balloon improves both weight and liver health in the short and long term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAFLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.